Egetis Therapeutics AB
€0.51
2
+€0.04+8.34% Today
Statistics
Day High
0.47
Day Low
0.47
52W High
0.57
52W Low
0.25
Volume
-
Avg. Volume
-
Mkt Cap
184.29M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
29AprExpected
Expected EPS
-0.18798454156
Actual EPS
N/A
Financials
-745.07%Profit Margin
Unprofitable8.07MRevenue
-60.16MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow P0F.F. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Egetis Therapeutics AB (publ), a pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment. The company's products pipeline includes Aladote, a drug to reduce the risk of acute liver injury associated with acetaminophen/paracetamol overdose, which is in phase IIb/III clinical trial; and Emcitate, a drug for the treatment of monocarboxylate transporter 8 (MCT8) deficiency, a debilitating rare disease with no available treatment. The company was formerly known as PledPharma AB (publ) and changed its name to Egetis Therapeutics AB (publ) in December 2020. Egetis Therapeutics AB (publ) was incorporated in 2006 and is based in Stockholm, Sweden.
Show more...
CEO
Mr. Nicklas Westerholm
Employees
42
Country
DE
ISIN
SE0003815604
WKN
000A1JH3B
Listings
0 Comments
Share your thoughts
FAQ
What is Egetis Therapeutics AB stock price today?▼
The current price of P0F.F is €0.51 EUR — it has increased by +8.34% in the past 24 hours. Watch Egetis Therapeutics AB stock price performance more closely on the chart.
What is Egetis Therapeutics AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Egetis Therapeutics AB stocks are traded under the ticker P0F.F.
Is Egetis Therapeutics AB stock price growing?▼
P0F.F stock has risen by +11.16% compared to the previous week, the month change is a +28.89% rise, over the last year Egetis Therapeutics AB has showed a +45.12% increase.
What is Egetis Therapeutics AB market cap?▼
Today Egetis Therapeutics AB has the market capitalization of 184.29M
When is the next Egetis Therapeutics AB earnings date?▼
Egetis Therapeutics AB is going to release the next earnings report on April 29, 2026.
What is Egetis Therapeutics AB revenue for the last year?▼
Egetis Therapeutics AB revenue for the last year amounts to 8.07M EUR.
What is Egetis Therapeutics AB net income for the last year?▼
P0F.F net income for the last year is -60.16M EUR.
How many employees does Egetis Therapeutics AB have?▼
As of April 02, 2026, the company has 42 employees.
In which sector is Egetis Therapeutics AB located?▼
Egetis Therapeutics AB operates in the Health Care sector.
When did Egetis Therapeutics AB complete a stock split?▼
Egetis Therapeutics AB has not had any recent stock splits.
Where is Egetis Therapeutics AB headquartered?▼
Egetis Therapeutics AB is headquartered in Stockholm, DE.